CRNX
Price
$31.88
Change
+$1.37 (+4.49%)
Updated
Jun 2 closing price
Capitalization
2.99B
66 days until earnings call
ZBIO
Price
$9.98
Change
-$0.08 (-0.80%)
Updated
Jun 3, 10:45 AM (EDT)
Capitalization
420.85M
Interact to see
Advertisement

CRNX vs ZBIO

Header iconCRNX vs ZBIO Comparison
Open Charts CRNX vs ZBIOBanner chart's image
Crinetics Pharmaceuticals
Price$31.88
Change+$1.37 (+4.49%)
Volume$824.7K
Capitalization2.99B
Zenas Biopharma
Price$9.98
Change-$0.08 (-0.80%)
Volume$400
Capitalization420.85M
CRNX vs ZBIO Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ZBIO commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and ZBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (CRNX: $31.88 vs. ZBIO: $10.06)
Brand notoriety: CRNX and ZBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 76% vs. ZBIO: 222%
Market capitalization -- CRNX: $2.99B vs. ZBIO: $420.85M
CRNX [@Biotechnology] is valued at $2.99B. ZBIO’s [@Biotechnology] market capitalization is $420.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileZBIO’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ZBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, ZBIO is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while ZBIO’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 3 bearish.
  • ZBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ZBIO.

Price Growth

CRNX (@Biotechnology) experienced а +7.12% price change this week, while ZBIO (@Biotechnology) price change was -11.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.43%. For the same industry, the average monthly price growth was +5.48%, and the average quarterly price growth was +2.00%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

ZBIO is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+8.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.99B) has a higher market cap than ZBIO($421M). ZBIO YTD gains are higher at: 22.833 vs. CRNX (-37.649). ZBIO has higher annual earnings (EBITDA): -163.75M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ZBIO (351M). ZBIO has less debt than CRNX: ZBIO (1M) vs CRNX (50.8M). ZBIO has higher revenues than CRNX: ZBIO (5M) vs CRNX (760K).
CRNXZBIOCRNX / ZBIO
Capitalization2.99B421M710%
EBITDA-373.49M-163.75M228%
Gain YTD-37.64922.833-165%
P/E RatioN/AN/A-
Revenue760K5M15%
Total Cash1.27B351M363%
Total Debt50.8M1M5,065%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXZBIO
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDSX2.05N/A
N/A
Midas Discovery
MUTHX25.35N/A
N/A
Franklin Mutual Shares Z
TADFX8.14N/A
N/A
Transamerica Sustainable Equity Inc R6
ARREX26.52N/A
N/A
American Century Real Estate R5
NWABX31.08N/A
N/A
Nationwide R6

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+4.49%
XNCR - CRNX
59%
Loosely correlated
+7.25%
IDYA - CRNX
56%
Loosely correlated
+6.69%
DYN - CRNX
56%
Loosely correlated
+6.19%
TRDA - CRNX
55%
Loosely correlated
+7.11%
RVMD - CRNX
55%
Loosely correlated
+3.17%
More

ZBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBIO has been loosely correlated with REPL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBIO jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBIO
1D Price
Change %
ZBIO100%
+5.67%
REPL - ZBIO
35%
Loosely correlated
+6.57%
SNDX - ZBIO
32%
Poorly correlated
+4.17%
KURA - ZBIO
30%
Poorly correlated
+10.72%
CRNX - ZBIO
30%
Poorly correlated
+4.49%
COYA - ZBIO
30%
Poorly correlated
+4.13%
More